LY2584702 Chemische Eigenschaften,Einsatz,Produktion Methoden
Verwenden
LY 2584702 is an orally available inhibitor of p70S6K signalling and potential antineoplastic activity. Used in combination with Erlotinib or Everolimus as an anti-tumor treatment.
LY2584702 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte